Related references
Note: Only part of the references are listed.Synthesis and structure-activity relationships of 4,5-fused pyridazinones as histamine H3 receptor antagonists
Ming Tao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
SAR studies of pyridazinone derivatives as novel glucan synthase inhibitors
Gang Zhou et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Derivatives of pyrrolo[3,4-d]pyridazinone, a new class of analgesic agents
Wieslaw Malinka et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: Synthesis and evaluation of their phosphodiesterase 4 inhibitory activity
Pierfrancesco Biagini et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Synthesis, characterization and antihypertensive activity of pyridazinone derivatives
Anees A. Siddiqui et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Recent advances in histamine H-3 receptor antagonists/inverse agonists
Dorota Lazewska et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Synthesis and analgesic and anti-inflammatory activities 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(p-substituted/nonsubstituted benzal)hydrazone derivatives
Mehtap Gokce et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Synthesis and vasodilatory activity of some amide derivatives of 6-(4-carboxymethyloxyphenyl)-4,5-dihydro-3(2H)-pyridazinone
Ranju Bansal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Synthesis and blood glucose lowering effect of novel pyridazinone substituted benzenesulfonylurea derivatives
I. G. Rathish et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
A review of levosimendan in the treatment of heart failure
Hulya Akhan Kasikcioglu et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2006)
An efficient multikilogram synthesis of ABT-963: A selective COX-2 inhibitor
FAJ Kerdesky et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2006)
Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative
SC Cherng et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
High-resolution crystal structure of aldose reductase complexed with the novel sulfonyl-pyridazinone inhibitor exhibiting an alternative active site anchoring group
H Steuber et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Cyclooxygenase: Past, present and future. A tribute to John R. Vane (1927-2004)
RM Botting
JOURNAL OF THERMAL BIOLOGY (2006)
Synthesis, analgesic, and anti-inflammatory activities of [6-(3,5-dimethyl-4-chloropyrazole-1-yl)-3(2H-pyridazinon-2-yl]acetamides
M Süküroglu et al.
ARCHIVES OF PHARMACAL RESEARCH (2005)
ABT-963 [2-(3,4-Difluoro-phenyl)-4-(3-hydroxy-3-methyl-butoxy)5-(4-methanesulfonyl-phenyl)-2H-pyridazin-3-one], a highly potent and selective disubstituted pyridazinone cyclooxgenase-2 inhibitor
RR Harris et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Some pyrrole substituted aryl pyridazinone and phthalazinone derivatives and their antihypertensive activities
S Demirayak et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2004)
Synthesis and anticonvulsant activity of novel 1-substituted-1,2-dihydropyridazine-3,6-diones
R Sivakumar et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2003)
A highly selective, non-hydantoin, non-carboxylic acid inhibitor of aldose reductase with potent oral activity in diabetic rat models:: 6-(5-chloro-3-methylbenzofuran-2-sulfonyl)-2-H-pyridazin-3-one
BL Mylari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Synthesis and structure-activity relationships of cis-tetrahydrophthalazinone/pyridazinone hybrids:: A novel series of potent dual PDE3/PDE4 inhibitory agents
M Van der Mey et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
α1-adrenoceptor antagonists.: 5.: Pyridazinone-arylpiperazines.: Probing the influence on affinity and selectivity of both ortho-alkoxy groups at the arylpiperazine moiety and cyclic substituents at the pyridazinone nucleus
L Betti et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Synthesis and antifeedant activity of new oxadiazolyl 3(2H)-pyridazinones
S Cao et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2003)
Levosimendan - A review of its use in the management of acute decompensated heart failure
CA Innes et al.
DRUGS (2003)
Arylpiperazines with affinity toward α1-adrenergic receptors
F Manetti et al.
CURRENT MEDICINAL CHEMISTRY (2002)
3-O-Substituted benzyl pyridazinone derivatives as COX inhibitors
VK Chintakunta et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2002)
Isoxazolo[3,4-d]pyridazinones and analogues as Leishmania mexicana PDE inhibitors
V Dal Piaz et al.
FARMACO (2002)
Levosimendan increases L-type Ca2+ current via phosphodiesterase-3 inhibition in human cardiac myocytes
Y Ajiro et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
5,6-diphenylpyridazine derivatives as acyl-CoA:cholesterol acyltransferase inhibitors
MP Giovannoni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Synthesis, biological evaluation, and pharmacophore generation of new pyridazinone derivatives with affinity toward α1- and α2-adrenoceptors
R Barbaro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Synthesis and antinociceptive activity of 6-substituted-3-pyridazinone derivatives
M Gokçe et al.
FARMACO (2001)
A novel pyridazinone derivative as a nonprostanoid PGI2 agonist
K Tsubaki et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
Share Paper
